20 Heart Attack Clinical Trials in Portland, IN (2026)

Q: Are there heart attack clinical trials in Portland?

Yes, there are 20 heart attack clinical trials currently recruiting in Portland, IN.

Q: How do I join a clinical trial in Portland?

Browse available studies, click one that interests you, and complete the free eligibility form. A study coordinator at the Portland research site will contact you.

Q: Are clinical trials in Portland free?

Yes, clinical trial participation is always free. Study-related treatments, medical tests, and doctor visits are provided at no cost.

Recruiting Heart Attack Studies in Portland

NCT05947851Recruiting

A Study of Nemtabrutinib Plus Venetoclax vs Venetoclax + Rituximab (VR) in Second-line (2L) + Relapsed/Refractory (R/R) Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL) (MK-1026-010/BELLWAVE-010).

The purpose of this study is to assess the safety and tolerability and to confirm the dose of nemtabrutinib in combination with venetoclax in participants with R/R CLL/SLL. The primary study hypothese...

Portland, IN735 participantsMerck Sharp & Dohme LLC

View Study Details

NCT07227155Recruiting

The HOPE Biobank Resource (BMT CTN 2402 HOPE)

A prospective, multicenter study that will establish a repository of biospecimens and clinical data from patients undergoing hematopoietic stem cell transplant (HCT) or gene therapy (GT) for treatment...

Portland, IN375 participantsMedical College of Wisconsin

View Study Details

NCT06233799Recruiting

Trial of Naltrexone/Bupropion for the Treatment of Methamphetamine Use Disorder

The primary objective of this study is to evaluate the efficacy of extended release naltrexone plus bupropion XL (XR-NTX/BUP-XL) compared to matched injectable and oral placebo (iPLB/oPLB) in reducing...

Portland, IN360 participantsNational Institute on Drug Abuse (NIDA)

View Study Details

NCT04877522Recruiting

Asciminib Roll-over Study

This is a long term safety study for patients who have completed a Novartis sponsored asciminib study and are judged by the investigator to benefit from continued treatment...

Portland, IN347 participantsNovartis Pharmaceuticals

View Study Details

NCT06370182Recruiting

Safety and Effectiveness of Mechanical Thrombectomy Using the Anaconda ANA Funnel Catheter

The objective of this study is to assess the safety and effectiveness of mechanical thrombectomy (MT) using the ANA funnel catheter in its intended use, which is to facilitate the navigation and deplo...

Portland, IN327 participantsAnaconda Biomed S.L.

View Study Details

NCT05462704Recruiting

Intravenous Versus Oral Iron for Treating Iron-Deficiency Anemia in Pregnancy

Double blind, placebo controlled, multicenter randomized trial in pregnant women in the U.S. (N=300) to test the central hypothesis that IV iron in pregnant women with IDA (Hb\<11 g/dL and ferritin\<3...

Portland, IN300 participantsWomen and Infants Hospital of Rhode Island

View Study Details

NCT04968834Recruiting

Protocol For Genomically Profiling, Collecting, Archiving And Distributing Blood And Bone Marrow Specimens From Children And Young Adults With Hematologic Malignancy

This research study is a genomic profiling and repository study for children and young adults who have leukemia, myelodysplastic syndrome (MDS) or myeloproliferative syndrome (MPS). Genes are the part...

Portland, IN300 participantsDana-Farber Cancer Institute

View Study Details

NCT07103733Recruiting

PRIMARY Ancillary Substudy

The PRIMARY trial (NCT05051033), which compares mitral valve repair (MVr) to transcatheter-edge-to-edge-repair (TEER), offers a platform for conducting mechanistic studies to develop early insights in...

Portland, IN250 participantsAnnetine Gelijns

View Study Details

NCT06400004Recruiting

Lumason® Infusion vs. Bolus Administrations

A phase III study designed as a randomized, within-patient comparison of continuous infusion of diluted Lumason® versus the bolus administration of undiluted Lumason® for degree of LVO and assessment ...

Portland, IN106 participantsBracco Diagnostics, Inc

View Study Details

NCT06950034Recruiting

A Phase 1 Study of STX-0712 in Patients With Advanced Hematological Malignancies (CMML and AML)

This is a first-in-human, multicenter, open-label, phase 1 study to evaluate the safety, PK, PD and preliminary efficacy of STX-0712 in patients with advanced CMML and AML for whom there are no furthe...

Portland, IN105 participantsSolu Therapeutics, Inc

View Study Details

NCT07228273Recruiting

Induction and Consolidation With Fludarabine, Cytarabine, Idarubicin, and Venetoclax for the Treatment of Acute Myeloid Leukemia

This phase II trial compares induction and consolidation therapy with fludarabine, cytarabine, idarubicin, and venetoclax to cytarabine and daunorubicin induction and cytarabine consolidation for the ...

Portland, IN102 participantsOHSU Knight Cancer Institute

View Study Details

NCT03874052Recruiting

Ruxolitinib in Combination With Venetoclax With and Without Azacitidine in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia

This phase I trial studies the side effects and best dose of ruxolitinib when given together with venetoclax and compares the effect of ruxolitinib in combination with venetoclax to venetoclax and aza...

Portland, IN51 participantsJennifer Saultz

View Study Details

NCT03004326Recruiting

Clinical Transcriptomics in Systemic Vasculitis (CUTIS)

Multi-center observational study to evaluate the histopathology and transcriptome of cutaneous lesions in patients with several different types of vasculitis....

Portland, IN50 participantsPeter Merkel

View Study Details

NCT05546580Recruiting

Study of Iadademstat and Gilteritinib in Patients With R/R AML With FMS-like Tyrosine Kinase Mutation (FLT3 Mut+)

Iadademstat is being studied as a treatment for subjects with Relapsed or Refractory Acute Myeloid Leukemia (R/R AML) with FMS-like tyrosine kinase mutation (FLT3 mut+). During the trial, iadademstat ...

Portland, IN50 participantsOryzon Genomics S.A.

View Study Details

NCT05591027Recruiting

Safety and Target Engagement of Centella Asiatica in Cognitive Impairment

This clinical trial is focused on determining whether biological signatures of target engagement by a Centella asiatica water extract product administered orally for 6 weeks can be measured in compari...

Portland, IN48 participantsOregon Health and Science University

View Study Details

NCT06121466Recruiting

Effect of Abdominal Wall Injections on Abdominal Pain

This is a prospective cohort study of outpatient adults with chronic abdominal wall pain receiving abdominal wall injections, as part of their usual care, with lidocaine. Subjects will be recruited at...

Portland, IN45 participantsOregon Health and Science University

View Study Details

NCT04659616Recruiting

Pemigatinib After Chemotherapy for the Treatment of Newly Diagnosed Acute Myeloid Leukemia

This phase I trial identifies the best dose and clinical benefit of giving pemigatinib following standard induction chemotherapy in patients with newly diagnosed acute myeloid leukemia. Pemigatinib se...

Portland, IN32 participantsOHSU Knight Cancer Institute

View Study Details

NCT06357182Recruiting

Iadademstat in Combination With Azacitidine and Venetoclax in Treating Newly Diagnosed Acute Myeloid Leukemia

This phase I trial tests the safety, side effects, and best dose of iadademstat when given together with azacitidine and venetoclax in treating patients with newly diagnosed acute myeloid leukemia (AM...

Portland, IN30 participantsOHSU Knight Cancer Institute

View Study Details

NCT05589896Recruiting

A First-in-Human Study of HLA-Partially to Fully Matched Allogenic Cryopreserved Deceased Donor Bone Marrow Transplantation for Patients With Hematologic Malignancies

The goal of this clinical trial is to determine the safety and feasibility of allogeneic transplantation with bone marrow from a deceased donor in patients with acute and chronic leukemias, myelodyspl...

Portland, IN12 participantsOssium Health, Inc.

View Study Details

NCT04529044Recruiting

177Lu-DOTATATE for the Treatment of Stage IV or Recurrent Breast Cancer

This phase II trial investigates how well 177Lu-DOTATATE works in treating patients with breast cancer that is stage IV or has come back (recurrent). 177Lu-DOTATATE may shrink or destroy the tumor or ...

Portland, IN10 participantsOHSU Knight Cancer Institute

View Study Details

About Heart Attack Clinical Trials in Portland

A heart attack (myocardial infarction) occurs when blood flow to part of the heart muscle is blocked, usually by a blood clot. It is a medical emergency requiring immediate treatment. Long-term management includes medications, lifestyle changes, and cardiac rehabilitation.

There are currently 20 heart attack clinical trials recruiting participants in Portland, IN. These studies are seeking a combined 3,635 participants. Research is being sponsored by Merck Sharp & Dohme LLC, Medical College of Wisconsin, National Institute on Drug Abuse (NIDA) and 13 other organizations. Clinical trial participation is free and participants receive study-related medical care at no cost.

Heart Attack Clinical Trials in Portland — FAQ

Are there heart attack clinical trials in Portland?

Yes, there are 20 heart attack clinical trials currently recruiting in Portland, IN. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Portland?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Portland research site will contact you about next steps.

Are clinical trials in Portland free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Portland studies also compensate for your time and travel.

What heart attack treatments are being tested?

The 20 active trials in Portland are testing new therapies including novel drugs, biologics, and treatment approaches for heart attack.

Data updated July 13, 2026 from ClinicalTrials.gov